These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33585885)

  • 1. Impact of Current Pain Status on Low-Barrier Buprenorphine Treatment Response Among Patients with Opioid Use Disorder.
    Peck KR; Ochalek TA; Streck JM; Badger GJ; Sigmon SC
    Pain Med; 2021 May; 22(5):1205-1212. PubMed ID: 33585885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults.
    Peck KR; Ochalek TA; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2020 Mar; 208():107879. PubMed ID: 31991327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms.
    Streck JM; Ochalek TA; Badger GJ; Sigmon SC
    Exp Clin Psychopharmacol; 2018 Aug; 26(4):403-409. PubMed ID: 29939049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR; Compton P; Giordano NA; Cheatle MD
    Drug Alcohol Depend; 2021 Apr; 221():108619. PubMed ID: 33667781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-subject evaluation of interim buprenorphine treatment during waitlist delays.
    Oleskowicz TN; Ochalek TA; Peck KR; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2021 Mar; 220():108532. PubMed ID: 33508690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of opioid rotation to buprenorphine/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder.
    Veldman S; van Beek M; van Rijswijk S; Ellerbroek H; Timmerman H; van der Wal S; Steegers M; Schellekens A
    Pain; 2022 May; 163(5):955-963. PubMed ID: 34433769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data.
    John WS; Mannelli P; Hoyle RH; Greenblatt L; Wu LT
    Drug Alcohol Depend Rep; 2022 Jun; 3():100048. PubMed ID: 36845986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.
    Sigmon SC; C Meyer A; Hruska B; Ochalek T; Rose G; Badger GJ; Brooklyn JR; Heil SH; Higgins ST; Moore BA; Schwartz RP
    Addict Behav; 2015 Dec; 51():136-42. PubMed ID: 26256469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR; Darnall BD; You DS
    JMIR Res Protoc; 2024 Jun; 13():e53784. PubMed ID: 38843513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an injectable monthly extended-release buprenorphine program in a low-barrier specialty addiction medicine clinic.
    Heil J; Salzman M; Hunter K; Baston KE; Milburn C; Schmidt R; Haroz R; Ganetsky VS
    J Subst Use Addict Treat; 2024 Jan; 156():209183. PubMed ID: 37879433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
    Leyde S; Price CJ; Colgan DD; Pike KC; Tsui JI; Merrill JO
    Subst Use Addctn J; 2024 Jul; 45(3):423-433. PubMed ID: 38327009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
    Greenwald MK; Wiest KL; Haight BR; Laffont CM; Zhao Y
    Harm Reduct J; 2023 Dec; 20(1):173. PubMed ID: 38042801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont.
    Peck KR; Moxley-Kelly N; Badger GJ; Sigmon SC
    Prev Med; 2021 Nov; 152(Pt 2):106817. PubMed ID: 34599919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials.
    Sigmon SC; Peck KR; Batchelder SR; Badger GJ; Heil SH; Higgins ST
    JAMA Netw Open; 2023 Sep; 6(9):e2331910. PubMed ID: 37755833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal thoughts and behaviors in patients with chronic pain, with and without co-occurring opioid use disorder.
    Cheatle MD; Giordano NA; Themelis K; Tang NKY
    Pain Med; 2023 Aug; 24(8):941-948. PubMed ID: 37014415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Conceptual Analysis of Opioid Use Disorder in Chronic Noncancer Pain Using Rodger's Evolutionary Approach.
    Kyei EF; Zhang L; Leveille S
    Pain Manag Nurs; 2024 Aug; 25(4):354-362. PubMed ID: 38729848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder.
    Schellekens AFA; Veldman SE; Suranto ESD; van Rijswijk SM; van der Wal SEI; Schene AH; van Beek MHCT
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
    Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
    J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders.
    Hammond CJ; Park G; Kady A; Rathod K; Rahman N; Vidal C; Wenzel K; Fishman M
    J Subst Abuse Treat; 2022 Feb; 133():108495. PubMed ID: 34218992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M
    J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.